Instead of four equal quarterly distributions, AstraZeneca insists on two payments per year, with a greater portion announced ...
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
We recently published a list of 10 Best Big-Name Stocks to Buy Right ... selling on individual US-listed stocks […] A Phase 3 ...
Americans love their Star-Spangled Banner, the French are obsessed with national pride but we Brits have a patriotism problem ...
FDA approves Lilly's eczema drug, Ebglyss, and the expanded use of Novartis' Kisqali, Merck's Keytruda and AstraZeneca's Fasenra.
Zacks.com on MSN3d
AZN Gets FDA Nod for Fasenra Label Expansion in Rare DiseaseThe FDA okays AstraZeneca's Fasenra for treating adults with eosinophilic granulomatosis with polyangiitis. This is the ...
Health and Me on MSN5d
GST Slashed On Three Cancer Drug: Here's How It Will Affect PatientsThe recent GST cut on cancer drugs could mean significant cost reductions for cancer treatment in India. Read to know how it ...
Aronne, MD, of Weill Cornell Medicine in New York City, made a compelling case that the next generation of obesity ...
Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...
GlobalData on MSN4d
Comparing the US’s ten most expensive drugs with prices in the UKPresident Donald Trump has made drug prices a core issue of his administration, causing consternation among US drug ...
The Federal Trade Commission is accusing three companies of artificially inflating insulin list prices. We have new developments on a deadly Israeli strike in Lebanon. The Food & Drug Administration .
The threshold between one season and another, between one moment and the next, between one way of being and the next one: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback